Isolation Beds Market Outlook 2027–2034: Size, Growth Drivers and Competitive Landscape

The rapid surge in infectious diseases such as COVID 19 and the necessity to contain the spread of these viral infections among healthcare workers are the primary drivers responsible for the demand of isolation bed across the globe.

Other factors such as technological breakthroughs in creating smart beds, remote control systems, customized functions for extended comfort, monitoring sensors, futuristic systems for health tracking, and barriers to protect geriatrics from bed fall are also supplementing the growth of this market. In line with this, the U.S. based manufacturer Stryker Corporation in April 2020 introduced its New Emergency Relief Bed line-ups to cater the surge in demand for the isolation bed due to COVID-19 situation. The company intended to manufacture 10,000 units per week to cater to its high demand in the healthcare facilities.

Industry Insights

Growth Drivers

The unexpected COVID-19 epidemic is the main factor behind the unexpected demand of the global isolation beds market. The dramatic changes occurred due to the COVID-19 pandemic, as a consequence of which demand for isolation bed is significantly growing. World Health Organization (WHO) has encouraged all concerned manufacturers to urgently raise their output. According to a WHO estimate in March 2020, the number of patients suffering from corona virus reached 200,000 and expected to reach to 100,000 in about twelve days.

Know more about this report: Download Sample Report

As COVID-19 is increasing on a larger scale, countries including China have reported that they are facing a lack of isolation beds because conventional bedding cannot fulfil the purpose. For instance, the Italian government has ordered in bulk of these beds for COVID-19 patients, as it was expected that by March 2020, more than 80 percent of the hospital beds would be acquired by the COVID-19 patients at Lombardy town of Italy.

COVID-19 patients, along with healthcare workers and people worldwide, are required to be provided as quickly as possible by personal protective equipment to deal with this global pandemic. In addition, the rapid production of isolation beds and protective equipment for healthcare workers is highly critical in order to overcome this condition, which leads significantly to the growth of the market.

Moreover, strong government actions also playing an important role in containing over-pricing of the COVID-19 treatment including isolation charges. In June 2020, the Government of India (GOI) has recommended to slash the cost by two-third in the private hospitals of Delhi. New applicable rates would be INR13,000 to 15,000/day and INR15,000 to 18,000/day for isolation bed without ventilator and with a ventilator respectively.

Know more about this report: Download Sample Report

Challenges

However, owing to the emergency lockout situation of COVID-19 in several nations, the isolation beds production and supply chain have been seriously impacted. Procurement, storage and delivery of raw materials and labor shortages in developing and established nations have had a detrimental effect on the optimal flow of output. These supply chain constraints are hampering the growth of the market.

Isolation Beds Market Report Scope

The market is primarily segmented on the basis of Type, Usage, By End-Use, and geographic region.

Source: Polaris Market Research Analysis

Know more about this report: Download Sample Report

Beds by Type Outlook

Based upon type, the global isolation beds market is bifurcated into hydraulic, manual, electric, and pneumatic. In 2019, the manual segment accounted for the largest share among all. The high share is attributed to maximum use of manual ones across different end users. The other factor is the low cost of manual bed as compared to others, which makes it affordable to all the healthcare settings.

The smart isolated bed is in immense demand. In this area, Australia-based Get to Sleep Simple, Hoana Medical Inc., the future medical start-up had developed an inexpensive price Smart Inclining Bedding solution, fitted with smart sensors mounted in the bedding to monitor patient activity and emergency warning.

Usage Outlook

Based on usage, the global market is bifurcated into bariatric, medical surgery, critical, pediatric, and maternal. Due to the global pandemic of COVID-19, there is a surge in hospital admissions across the globe, this has resulted in unexpected demand of the critical segment. The segment is anticipated to grow significantly over the study timeframe. Moreover, in 2025, the medical surgery segment is expected to account for the largest revenue. The growing need for intensive care units and expected government funding to fill the gap in existing healthcare infrastructure would supplement the segment’s growth.

End Use Outlook

Based on end use, the market is bifurcated into general & acute care hospitals, specialized hospitals, multi-specialty hospitals, and others. In 2019, the general and acute hospital segment accounted for the largest market share and it is expected to retain this domination till 2027. The number of general and acute hospitals is more as compared to others, so the penetration of these beds is high, thereby contributing to its highest share.

Regional Outlook

Geographically, owing to the tremendous amount of COVID-19 patients in the area, North America is the largest contributor to sales in the global isolation beds market. The region's demand for these beddings is 10 times greater than what's accessible in stock. Countries like Germany, France, Spain, Italy and the UK anticipated to have the highest number of cases. Also because of the inaccessibility of protective equipment, doctors are threatening to quit jobs in Europe.

As a consequence, respective governments projected to invest more than USD 265 million on personal protective, including isolation beds. With the continuous rise in the COVID-19 cases in North America the demand for the isolation bed is projected to rise in the short term. The region registered more than 18,763 deaths as of the first week of April 2020.

Moreover, Asia-Pacific is expected to witness substantial growth over the forecast period. The COVID-19 epidemic spread from China, as a consequence of which there was a shortage of raw materials in the U.S. The pandemic outbreak tanked Chinese economy, although the country has started recovering and even initiated medical supplies to the and European Union. To limit the spread of community transmissions among the Chinese population, the government had introduced the establishment of Fangcang shelter hospitals at larger public places such as stadium, halls, and exhibition centres.

Government funds also play an important role in tackling the ongoing COVID-19 pandemic. In line with this, several countries such as France, the UK, Germany, and Spain have promised to allocate dedicated funds USD 50 billion, USD 14.8 billion, USD 808 billion, and USD 223 billion, respectively. This huge initiative undertaken by the individual government will enable several stakeholders to fight with the COVID-19 pandemic.

Competitive Landscape

Invacare Corporation
Arjo Huntleigh (part of Gentige AB)
Savion Industries Ltd.
Joerns Healthcare
Joh. Stiegelmeyer GmbH
LINET Group
Stryker Corporation
Span-America Medical Systems
Gendron Inc.
Paramount Bed Holdings
Hill Rom Inc.
Medline Industries
alvestio S.P.A. among others.

These players focus their energies on strategic mergers and acquisitions to extend their R&D capabilities which might assist them in coming up with novel technologies and thereby gain a competitive edge.  For instance, the U.S based company Asset Homes announced in March 2020 announced to provide these beds to the hospitals based in India.

Recent Developments

In October 2026, Sphaira, a medical technology company headquartered in Germany, was working to advance the clinical application of its MOBY P1 mobile patient isolation system, which was already being used at Charité-Universitättsmedizin Berlin. It creates a filtered, controlled environment around patients, allowing them to move beyond the confines of traditional isolation rooms, but still contained for protection. This development directly supports the patient isolation equipment market by illustrating the clinical use of mobile isolation technology and generating opportunities for more adaptable infection control solutions. (Source: Founderland)

In April 2026, Rowland Emergency, a US-based supplier of emergency medical equipment, announced a distribution agreement with Norwegian medical isolation transport systems maker EpiGuard. According to the deal, Rowland Emergency was given permission to sell EpiGuard's EpiShuttle isolation transport system for critical care providers, emergency medical services, and air medical transport. The development supports the isolation beds and patient containment equipment ecosystem by enabling access to specialized systems that minimize contamination risks during patient transport. (Source: Rowland Emergency)

In March 2026, Carecubes announced the finished a USD 6.5 million Series A funding round to scale its FDA-cleared Carecube isolation technology. Healthcare systems in 13 U.S. states and territories and 36 communities have bought the company’s isolation units, it said. This development supports the commercialization of rapid-deployment infection-control systems designed to enable patient isolation outside of traditional dedicated isolation rooms, supporting the isolation beds and patient containment market. (Source: Carecubes)